Sensex recoups 350pts from day's low, ends flat; Nifty holds 18K; SBI up 2%

CLOSING BELL: IT, Power stocks logged significant losses, even as select financial stocks gained.

1:54 PM

Global Check:: Asian markets in red post US Fed rate hike; Hang Seng slumps 3%

Source: Yahoo Finance

1:47 PM

Moody's downgrades Italian economy amid inflation, energy concerns

Moody's slashed its assessment of the country's banking system from "stable" to "negative", and said it expects conditions for the banking sector to deteriorate further over the coming 12 to 18 months. READ MORE

1:37 PM

Cognizant cuts revenue forecast, flags attrition impact on business

Unlike its peers, Nasdaq-listed IT services firm Cognizant continues to see attrition that is impacting operations. The company, in its Q3 results report, guided for a decline in Q4 and full-year revenue. READ MORE

1:27 PM

Sensex 30 Heatmap:: SBI, Airtel shine; Power, IT stocks whine

1:17 PM

BSE 500:: Top gainers so far

MAS Financial Services up over 12 per cent was the top gainer among the BSE 500 stocks so far on Thursday. It was followed by M&M Financial Services, Mazagon Dock, Alembic Pharma and Mishra Dhatu Nigam, up over 7 per cent each.

1:07 PM

Cochin Shipyard hits new high after a 5-year gap; zooms 96% in 4 months

CSL made its stock market debut on August 11, 2017. The company issued shares at price of Rs 432 per share. The retail individual investors and the employees of CSL were given a discount of 5 per cent (approx.) and the shares were offered to them at Rs 411 per share. READ MORE

12:57 PM

Sept Quarter Results :: Adani Wilmar's consolidated net profit falls 73% YoY

>> PAT at Rs 48.7 crore vs Rs 182.3 crore YoY

> >Revenue at Rs 14,150 cr vs Rs 13,558 cr, up 4.4% YoY

 

>> EBITDA at Rs 254.5 cr vs Rs 430 cr, down 40.8% YoY

 

>> Margin at 1.8% vs 3.3% YoY
 

12:47 PM

Global Health IPO :: Subscribe for long-term, says Anand Rathi

Global Health Limited operating under brand name “Medanta” is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity and operating revenues. It is recognized for clinical expertise in particular in dealing with complicated cases. The Company has focus on under-served areas with dense population and presence in top or capital cities of large states (NCR, Lucknow and Patna).

The company is available at the upper end of the IPO price band at 38.4x its FY23 annualized earnings attributable to post issue equity demanding a market cap of Rs. 90,110 million. At the upper end of the IPO price band, the issue is priced at a P/BV of 5.3x based on its NAV of Rs. 63.82 as of March 31, 2022.

The Company have good operating metrics and financial profile with topline and margin increasing over years. When compared to its listed peers, Medanta is fairly valued. We recommend a "Subscribe-Long Term" rating to this IPO.

12:38 PM

GNFC, Deepak Fertilisers can soar up to 35%, hint charts; avoid Chambal

Barring, Chambal Fertilizers & Chemicals, which has shed 19 per cent on YTD basis, most of the other fertilizers stock have logged gains so far in 2022. Deepak Fertilisers has zoomed 148 per cent. READ MORE

12:29 PM

Geopolitical situation a bigger worry for markets than rate hikes: Analysts

"The conflict between Iran and Saudi Arabia is another geopolitical worry. All this will have an economic implication as well, as it will impact the crucial energy supply especially at this time of the year when the winter is likely to be harsh. The food supplies can also be hit. In case there is an unfortunate geopolitical event, it will fan inflation concerns and growth rates across economies. Geopolitical tensions are ranked numero uno when it comes to what can hurt market sentiment over the next few months," said Gaurang Shah, head investment strategist at Geojit Financial Services. READ MORE

12:14 PM

After Fed hike, experts can't form consensus on expected MPC response

The monetary policy committee (MPC) has to take cognisance of the US Federal Reserve's fourth straight rate hike of 75 basis points in its December policy review, say some experts. Others believe that the RBI panel may go slow in its December policy onwards, despite the Fed decision. READ MORE

12:02 PM

Sept Quarter Results :: Devyani International reports PAT of Rs 58.7 crore

>> Revenue increases to Rs 747.4 crore

>> Ebitda rises to Rs 166.4 crore

>> Ebitda margin shrinks to 22.3% 

12:02 PM

Alembic Pharma surges 8% after USFDA nod to Ketorolac injection

11:56 AM

MARKET CHECK: Sensex at day's low, down over 100 points

11:45 AM

Kinetic Engg gains 1% after firm allots 8.7 lakh shares on pref basis